Barclays Cuts Teladoc Health (NYSE:TDOC) Price Target to $20.00

Teladoc Health (NYSE:TDOC) had its price objective lowered by Barclays from $25.00 to $20.00 in a report released on Friday morning, Benzinga reports. Barclays currently has an overweight rating on the health services provider’s stock.

Several other research firms have also commented on TDOC. DA Davidson dropped their target price on Teladoc Health from $22.00 to $18.00 and set a neutral rating for the company in a research note on Wednesday, February 21st. Citigroup cut their price objective on shares of Teladoc Health from $21.00 to $19.00 and set a neutral rating on the stock in a report on Wednesday, February 21st. Cantor Fitzgerald began coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They set an overweight rating and a $22.00 price target for the company. Piper Sandler lowered their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an overweight rating for the company in a research note on Wednesday, February 21st. Finally, SVB Leerink assumed coverage on Teladoc Health in a research report on Monday, February 26th. They issued a market perform rating and a $17.00 target price on the stock. Eleven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of Hold and an average target price of $19.67.

Teladoc Health Stock Down 2.4 %

Teladoc Health stock opened at $13.01 on Friday. The firm’s 50-day moving average is $15.01 and its two-hundred day moving average is $17.77. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66. Teladoc Health has a 12-month low of $12.65 and a 12-month high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The firm had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 10.11% and a negative net margin of 8.90%. The firm’s revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the business posted ($0.37) EPS. On average, equities analysts anticipate that Teladoc Health will post -1.07 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, COO Michael Willem Waters sold 4,523 shares of the company’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $86,751.14. Following the completion of the transaction, the chief operating officer now owns 38,570 shares in the company, valued at approximately $739,772.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Teladoc Health news, COO Michael Willem Waters sold 4,523 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $86,751.14. Following the transaction, the chief operating officer now owns 38,570 shares in the company, valued at approximately $739,772.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Laizer Kornwasser sold 7,882 shares of the company’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $151,176.76. Following the completion of the transaction, the insider now directly owns 57,223 shares of the company’s stock, valued at $1,097,537.14. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 135,441 shares of company stock worth $2,038,251. 1.63% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors have recently made changes to their positions in TDOC. ARK Investment Management LLC raised its stake in shares of Teladoc Health by 4.5% in the 4th quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider’s stock valued at $457,389,000 after purchasing an additional 912,692 shares in the last quarter. Vanguard Group Inc. increased its holdings in Teladoc Health by 11.8% in the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after buying an additional 1,855,480 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Teladoc Health by 25.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock valued at $82,636,000 after buying an additional 767,999 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Teladoc Health by 6.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,654,116 shares of the health services provider’s stock worth $35,646,000 after buying an additional 104,531 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Teladoc Health by 9.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 658,435 shares of the health services provider’s stock worth $12,240,000 after acquiring an additional 57,989 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.